nodes	percent_of_prediction	percent_of_DWPC	metapath
Rotigotine—Parkinson's disease—Clonazepam—epilepsy syndrome	0.23	0.554	CpDpCtD
Rotigotine—Parkinson's disease—Gabapentin—epilepsy syndrome	0.185	0.446	CpDpCtD
Rotigotine—CYP2D6—epilepsy syndrome	0.107	1	CbGaD
Rotigotine—CYP1A2—Carbamazepine—epilepsy syndrome	0.0143	0.0662	CbGbCtD
Rotigotine—CYP1A2—Primidone—epilepsy syndrome	0.0134	0.0618	CbGbCtD
Rotigotine—CYP1A2—Propofol—epilepsy syndrome	0.012	0.0554	CbGbCtD
Rotigotine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0119	0.0552	CbGbCtD
Rotigotine—CYP1A2—Phenobarbital—epilepsy syndrome	0.0114	0.0529	CbGbCtD
Rotigotine—CYP3A4—Felbamate—epilepsy syndrome	0.0111	0.0513	CbGbCtD
Rotigotine—CYP3A4—Trimethadione—epilepsy syndrome	0.0111	0.0513	CbGbCtD
Rotigotine—CYP1A2—Diazepam—epilepsy syndrome	0.0109	0.0502	CbGbCtD
Rotigotine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0104	0.0483	CbGbCtD
Rotigotine—CYP2D6—Propofol—epilepsy syndrome	0.00987	0.0456	CbGbCtD
Rotigotine—CYP3A4—Clonazepam—epilepsy syndrome	0.00944	0.0436	CbGbCtD
Rotigotine—CYP3A4—Clobazam—epilepsy syndrome	0.00905	0.0418	CbGbCtD
Rotigotine—CYP1A2—Valproic Acid—epilepsy syndrome	0.00855	0.0395	CbGbCtD
Rotigotine—CYP3A4—Rufinamide—epilepsy syndrome	0.0077	0.0356	CbGbCtD
Rotigotine—CYP3A4—Carbamazepine—epilepsy syndrome	0.0075	0.0347	CbGbCtD
Rotigotine—CYP3A4—Primidone—epilepsy syndrome	0.007	0.0324	CbGbCtD
Rotigotine—CYP3A4—Phenytoin—epilepsy syndrome	0.00673	0.0311	CbGbCtD
Rotigotine—CYP3A4—Propofol—epilepsy syndrome	0.00628	0.029	CbGbCtD
Rotigotine—CYP3A4—Acetazolamide—epilepsy syndrome	0.006	0.0277	CbGbCtD
Rotigotine—CYP3A4—Phenobarbital—epilepsy syndrome	0.006	0.0277	CbGbCtD
Rotigotine—CYP3A4—Midazolam—epilepsy syndrome	0.00591	0.0273	CbGbCtD
Rotigotine—CYP3A4—Diazepam—epilepsy syndrome	0.00569	0.0263	CbGbCtD
Rotigotine—CYP3A4—Zonisamide—epilepsy syndrome	0.00555	0.0256	CbGbCtD
Rotigotine—CYP3A4—Valproic Acid—epilepsy syndrome	0.00448	0.0207	CbGbCtD
Rotigotine—CYP3A4—Topiramate—epilepsy syndrome	0.00404	0.0187	CbGbCtD
Rotigotine—DRD3—telencephalic ventricle—epilepsy syndrome	0.00356	0.106	CbGeAlD
Rotigotine—DRD1—telencephalic ventricle—epilepsy syndrome	0.00255	0.0761	CbGeAlD
Rotigotine—DRD5—ganglion—epilepsy syndrome	0.00208	0.062	CbGeAlD
Rotigotine—HTR1A—telencephalic ventricle—epilepsy syndrome	0.00167	0.0498	CbGeAlD
Rotigotine—DRD1—ganglion—epilepsy syndrome	0.00159	0.0474	CbGeAlD
Rotigotine—DRD2—telencephalic ventricle—epilepsy syndrome	0.0015	0.045	CbGeAlD
Rotigotine—HTR1A—ganglion—epilepsy syndrome	0.00104	0.031	CbGeAlD
Rotigotine—DRD2—ganglion—epilepsy syndrome	0.000937	0.028	CbGeAlD
Rotigotine—DRD5—forebrain—epilepsy syndrome	0.000871	0.026	CbGeAlD
Rotigotine—DRD5—telencephalon—epilepsy syndrome	0.0008	0.0239	CbGeAlD
Rotigotine—HTR1A—hindbrain—epilepsy syndrome	0.000786	0.0235	CbGeAlD
Rotigotine—DRD2—hindbrain—epilepsy syndrome	0.00071	0.0212	CbGeAlD
Rotigotine—DRD1—brainstem—epilepsy syndrome	0.000689	0.0206	CbGeAlD
Rotigotine—DRD1—forebrain—epilepsy syndrome	0.000665	0.0199	CbGeAlD
Rotigotine—DRD1—telencephalon—epilepsy syndrome	0.000612	0.0183	CbGeAlD
Rotigotine—DRD4—brain—epilepsy syndrome	0.000548	0.0164	CbGeAlD
Rotigotine—DRD3—head—epilepsy syndrome	0.000532	0.0159	CbGeAlD
Rotigotine—DRD3—nervous system—epilepsy syndrome	0.000504	0.0151	CbGeAlD
Rotigotine—DRD5—head—epilepsy syndrome	0.000498	0.0149	CbGeAlD
Rotigotine—DRD3—central nervous system—epilepsy syndrome	0.000485	0.0145	CbGeAlD
Rotigotine—DRD5—nervous system—epilepsy syndrome	0.000473	0.0141	CbGeAlD
Rotigotine—DRD5—central nervous system—epilepsy syndrome	0.000455	0.0136	CbGeAlD
Rotigotine—HTR1A—brainstem—epilepsy syndrome	0.000451	0.0135	CbGeAlD
Rotigotine—DRD1—midbrain—epilepsy syndrome	0.000439	0.0131	CbGeAlD
Rotigotine—HTR1A—forebrain—epilepsy syndrome	0.000435	0.013	CbGeAlD
Rotigotine—CYP2D6—hindbrain—epilepsy syndrome	0.000427	0.0128	CbGeAlD
Rotigotine—DRD2—brainstem—epilepsy syndrome	0.000407	0.0122	CbGeAlD
Rotigotine—HTR1A—telencephalon—epilepsy syndrome	0.0004	0.0119	CbGeAlD
Rotigotine—DRD2—forebrain—epilepsy syndrome	0.000393	0.0117	CbGeAlD
Rotigotine—DRD3—brain—epilepsy syndrome	0.000385	0.0115	CbGeAlD
Rotigotine—DRD1—head—epilepsy syndrome	0.000381	0.0114	CbGeAlD
Rotigotine—DRD2—telencephalon—epilepsy syndrome	0.000361	0.0108	CbGeAlD
Rotigotine—DRD5—brain—epilepsy syndrome	0.000361	0.0108	CbGeAlD
Rotigotine—DRD1—nervous system—epilepsy syndrome	0.000361	0.0108	CbGeAlD
Rotigotine—DRD1—central nervous system—epilepsy syndrome	0.000348	0.0104	CbGeAlD
Rotigotine—HTR1A—midbrain—epilepsy syndrome	0.000287	0.00858	CbGeAlD
Rotigotine—HTR1A—spinal cord—epilepsy syndrome	0.00028	0.00837	CbGeAlD
Rotigotine—DRD1—brain—epilepsy syndrome	0.000276	0.00825	CbGeAlD
Rotigotine—DRD2—midbrain—epilepsy syndrome	0.00026	0.00775	CbGeAlD
Rotigotine—HTR1A—head—epilepsy syndrome	0.000249	0.00744	CbGeAlD
Rotigotine—CYP2D6—brainstem—epilepsy syndrome	0.000245	0.00731	CbGeAlD
Rotigotine—CYP2D6—forebrain—epilepsy syndrome	0.000236	0.00705	CbGeAlD
Rotigotine—HTR1A—nervous system—epilepsy syndrome	0.000236	0.00705	CbGeAlD
Rotigotine—HTR1A—central nervous system—epilepsy syndrome	0.000227	0.00679	CbGeAlD
Rotigotine—DRD2—head—epilepsy syndrome	0.000225	0.00672	CbGeAlD
Rotigotine—HTR1A—cerebellum—epilepsy syndrome	0.000222	0.00664	CbGeAlD
Rotigotine—CYP2D6—telencephalon—epilepsy syndrome	0.000217	0.00649	CbGeAlD
Rotigotine—DRD2—nervous system—epilepsy syndrome	0.000213	0.00637	CbGeAlD
Rotigotine—DRD2—central nervous system—epilepsy syndrome	0.000205	0.00614	CbGeAlD
Rotigotine—DRD2—cerebellum—epilepsy syndrome	0.000201	0.006	CbGeAlD
Rotigotine—HTR1A—brain—epilepsy syndrome	0.00018	0.00539	CbGeAlD
Rotigotine—DRD2—brain—epilepsy syndrome	0.000163	0.00487	CbGeAlD
Rotigotine—CYP2D6—head—epilepsy syndrome	0.000135	0.00404	CbGeAlD
Rotigotine—CYP3A4—nervous system—epilepsy syndrome	0.00013	0.00389	CbGeAlD
Rotigotine—CYP2D6—nervous system—epilepsy syndrome	0.000128	0.00383	CbGeAlD
Rotigotine—CYP3A4—central nervous system—epilepsy syndrome	0.000125	0.00375	CbGeAlD
Rotigotine—CYP2D6—central nervous system—epilepsy syndrome	0.000123	0.00369	CbGeAlD
Rotigotine—CYP2D6—cerebellum—epilepsy syndrome	0.000121	0.0036	CbGeAlD
Rotigotine—CYP2D6—brain—epilepsy syndrome	9.8e-05	0.00293	CbGeAlD
Rotigotine—Hypersensitivity—Phenytoin—epilepsy syndrome	5.37e-05	0.000365	CcSEcCtD
Rotigotine—Urticaria—Lamotrigine—epilepsy syndrome	5.35e-05	0.000363	CcSEcCtD
Rotigotine—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	5.35e-05	0.000363	CcSEcCtD
Rotigotine—Malaise—Pregabalin—epilepsy syndrome	5.34e-05	0.000363	CcSEcCtD
Rotigotine—Nausea—Propofol—epilepsy syndrome	5.34e-05	0.000363	CcSEcCtD
Rotigotine—Vomiting—Fosphenytoin—epilepsy syndrome	5.33e-05	0.000362	CcSEcCtD
Rotigotine—Diarrhoea—Felbamate—epilepsy syndrome	5.33e-05	0.000362	CcSEcCtD
Rotigotine—Vertigo—Pregabalin—epilepsy syndrome	5.32e-05	0.000361	CcSEcCtD
Rotigotine—Dizziness—Diazepam—epilepsy syndrome	5.32e-05	0.000361	CcSEcCtD
Rotigotine—Infection—Valproic Acid—epilepsy syndrome	5.31e-05	0.000361	CcSEcCtD
Rotigotine—Syncope—Pregabalin—epilepsy syndrome	5.31e-05	0.000361	CcSEcCtD
Rotigotine—Rash—Fosphenytoin—epilepsy syndrome	5.28e-05	0.000359	CcSEcCtD
Rotigotine—Dermatitis—Fosphenytoin—epilepsy syndrome	5.28e-05	0.000358	CcSEcCtD
Rotigotine—Asthenia—Clonazepam—epilepsy syndrome	5.27e-05	0.000358	CcSEcCtD
Rotigotine—Headache—Fosphenytoin—epilepsy syndrome	5.25e-05	0.000357	CcSEcCtD
Rotigotine—Nervous system disorder—Valproic Acid—epilepsy syndrome	5.24e-05	0.000356	CcSEcCtD
Rotigotine—Asthenia—Phenytoin—epilepsy syndrome	5.23e-05	0.000355	CcSEcCtD
Rotigotine—Nausea—Midazolam—epilepsy syndrome	5.22e-05	0.000355	CcSEcCtD
Rotigotine—Hallucination—Topiramate—epilepsy syndrome	5.22e-05	0.000355	CcSEcCtD
Rotigotine—Muscle spasms—Gabapentin—epilepsy syndrome	5.22e-05	0.000355	CcSEcCtD
Rotigotine—Diarrhoea—Zonisamide—epilepsy syndrome	5.21e-05	0.000354	CcSEcCtD
Rotigotine—Loss of consciousness—Pregabalin—epilepsy syndrome	5.21e-05	0.000354	CcSEcCtD
Rotigotine—Asthenia—Oxcarbazepine—epilepsy syndrome	5.21e-05	0.000353	CcSEcCtD
Rotigotine—Pruritus—Clonazepam—epilepsy syndrome	5.2e-05	0.000353	CcSEcCtD
Rotigotine—Vomiting—Vigabatrin—epilepsy syndrome	5.19e-05	0.000353	CcSEcCtD
Rotigotine—Skin disorder—Valproic Acid—epilepsy syndrome	5.19e-05	0.000353	CcSEcCtD
Rotigotine—Oedema peripheral—Topiramate—epilepsy syndrome	5.17e-05	0.000351	CcSEcCtD
Rotigotine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	5.17e-05	0.000351	CcSEcCtD
Rotigotine—Cough—Pregabalin—epilepsy syndrome	5.17e-05	0.000351	CcSEcCtD
Rotigotine—Pruritus—Phenytoin—epilepsy syndrome	5.16e-05	0.00035	CcSEcCtD
Rotigotine—Connective tissue disorder—Topiramate—epilepsy syndrome	5.16e-05	0.00035	CcSEcCtD
Rotigotine—Nausea—Levetiracetam—epilepsy syndrome	5.16e-05	0.00035	CcSEcCtD
Rotigotine—Rash—Vigabatrin—epilepsy syndrome	5.15e-05	0.00035	CcSEcCtD
Rotigotine—Dizziness—Felbamate—epilepsy syndrome	5.15e-05	0.00035	CcSEcCtD
Rotigotine—Dermatitis—Vigabatrin—epilepsy syndrome	5.15e-05	0.000349	CcSEcCtD
Rotigotine—Pruritus—Oxcarbazepine—epilepsy syndrome	5.13e-05	0.000349	CcSEcCtD
Rotigotine—Hypersensitivity—Carbamazepine—epilepsy syndrome	5.13e-05	0.000348	CcSEcCtD
Rotigotine—Headache—Vigabatrin—epilepsy syndrome	5.12e-05	0.000348	CcSEcCtD
Rotigotine—Hypertension—Pregabalin—epilepsy syndrome	5.11e-05	0.000347	CcSEcCtD
Rotigotine—Vomiting—Diazepam—epilepsy syndrome	5.11e-05	0.000347	CcSEcCtD
Rotigotine—Anorexia—Valproic Acid—epilepsy syndrome	5.1e-05	0.000346	CcSEcCtD
Rotigotine—Tremor—Gabapentin—epilepsy syndrome	5.09e-05	0.000346	CcSEcCtD
Rotigotine—Rash—Diazepam—epilepsy syndrome	5.07e-05	0.000344	CcSEcCtD
Rotigotine—Dermatitis—Diazepam—epilepsy syndrome	5.07e-05	0.000344	CcSEcCtD
Rotigotine—Visual impairment—Topiramate—epilepsy syndrome	5.06e-05	0.000344	CcSEcCtD
Rotigotine—Arthralgia—Pregabalin—epilepsy syndrome	5.04e-05	0.000342	CcSEcCtD
Rotigotine—Ill-defined disorder—Gabapentin—epilepsy syndrome	5.04e-05	0.000342	CcSEcCtD
Rotigotine—Dizziness—Zonisamide—epilepsy syndrome	5.04e-05	0.000342	CcSEcCtD
Rotigotine—Headache—Diazepam—epilepsy syndrome	5.04e-05	0.000342	CcSEcCtD
Rotigotine—Diarrhoea—Clonazepam—epilepsy syndrome	5.02e-05	0.000341	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	5.01e-05	0.00034	CcSEcCtD
Rotigotine—Hypotension—Valproic Acid—epilepsy syndrome	5e-05	0.000339	CcSEcCtD
Rotigotine—Asthenia—Carbamazepine—epilepsy syndrome	5e-05	0.000339	CcSEcCtD
Rotigotine—Agitation—Gabapentin—epilepsy syndrome	4.99e-05	0.000339	CcSEcCtD
Rotigotine—Diarrhoea—Phenytoin—epilepsy syndrome	4.99e-05	0.000339	CcSEcCtD
Rotigotine—Discomfort—Pregabalin—epilepsy syndrome	4.98e-05	0.000338	CcSEcCtD
Rotigotine—Nausea—Fosphenytoin—epilepsy syndrome	4.98e-05	0.000338	CcSEcCtD
Rotigotine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.96e-05	0.000337	CcSEcCtD
Rotigotine—Angioedema—Gabapentin—epilepsy syndrome	4.96e-05	0.000337	CcSEcCtD
Rotigotine—Hypersensitivity—Lamotrigine—epilepsy syndrome	4.96e-05	0.000337	CcSEcCtD
Rotigotine—Vomiting—Felbamate—epilepsy syndrome	4.95e-05	0.000336	CcSEcCtD
Rotigotine—Dry mouth—Pregabalin—epilepsy syndrome	4.93e-05	0.000335	CcSEcCtD
Rotigotine—Pruritus—Carbamazepine—epilepsy syndrome	4.93e-05	0.000335	CcSEcCtD
Rotigotine—Rash—Felbamate—epilepsy syndrome	4.91e-05	0.000333	CcSEcCtD
Rotigotine—Dermatitis—Felbamate—epilepsy syndrome	4.9e-05	0.000333	CcSEcCtD
Rotigotine—Malaise—Gabapentin—epilepsy syndrome	4.9e-05	0.000333	CcSEcCtD
Rotigotine—Tinnitus—Topiramate—epilepsy syndrome	4.89e-05	0.000332	CcSEcCtD
Rotigotine—Vertigo—Gabapentin—epilepsy syndrome	4.88e-05	0.000331	CcSEcCtD
Rotigotine—Headache—Felbamate—epilepsy syndrome	4.88e-05	0.000331	CcSEcCtD
Rotigotine—Confusional state—Pregabalin—epilepsy syndrome	4.87e-05	0.000331	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	4.87e-05	0.000331	CcSEcCtD
Rotigotine—Syncope—Gabapentin—epilepsy syndrome	4.87e-05	0.000331	CcSEcCtD
Rotigotine—Dizziness—Clonazepam—epilepsy syndrome	4.86e-05	0.00033	CcSEcCtD
Rotigotine—Nausea—Vigabatrin—epilepsy syndrome	4.85e-05	0.00033	CcSEcCtD
Rotigotine—Vomiting—Zonisamide—epilepsy syndrome	4.84e-05	0.000329	CcSEcCtD
Rotigotine—Insomnia—Valproic Acid—epilepsy syndrome	4.84e-05	0.000328	CcSEcCtD
Rotigotine—Asthenia—Lamotrigine—epilepsy syndrome	4.83e-05	0.000328	CcSEcCtD
Rotigotine—Dizziness—Phenytoin—epilepsy syndrome	4.82e-05	0.000328	CcSEcCtD
Rotigotine—Rash—Zonisamide—epilepsy syndrome	4.8e-05	0.000326	CcSEcCtD
Rotigotine—Infection—Pregabalin—epilepsy syndrome	4.8e-05	0.000326	CcSEcCtD
Rotigotine—Paraesthesia—Valproic Acid—epilepsy syndrome	4.8e-05	0.000326	CcSEcCtD
Rotigotine—Dermatitis—Zonisamide—epilepsy syndrome	4.8e-05	0.000326	CcSEcCtD
Rotigotine—Dizziness—Oxcarbazepine—epilepsy syndrome	4.8e-05	0.000326	CcSEcCtD
Rotigotine—Nausea—Diazepam—epilepsy syndrome	4.78e-05	0.000324	CcSEcCtD
Rotigotine—Loss of consciousness—Gabapentin—epilepsy syndrome	4.77e-05	0.000324	CcSEcCtD
Rotigotine—Headache—Zonisamide—epilepsy syndrome	4.77e-05	0.000324	CcSEcCtD
Rotigotine—Diarrhoea—Carbamazepine—epilepsy syndrome	4.76e-05	0.000323	CcSEcCtD
Rotigotine—Angiopathy—Topiramate—epilepsy syndrome	4.76e-05	0.000323	CcSEcCtD
Rotigotine—Pruritus—Lamotrigine—epilepsy syndrome	4.76e-05	0.000323	CcSEcCtD
Rotigotine—Shock—Pregabalin—epilepsy syndrome	4.76e-05	0.000323	CcSEcCtD
Rotigotine—Somnolence—Valproic Acid—epilepsy syndrome	4.75e-05	0.000323	CcSEcCtD
Rotigotine—Immune system disorder—Topiramate—epilepsy syndrome	4.74e-05	0.000322	CcSEcCtD
Rotigotine—Nervous system disorder—Pregabalin—epilepsy syndrome	4.74e-05	0.000322	CcSEcCtD
Rotigotine—Cough—Gabapentin—epilepsy syndrome	4.74e-05	0.000322	CcSEcCtD
Rotigotine—Mediastinal disorder—Topiramate—epilepsy syndrome	4.73e-05	0.000321	CcSEcCtD
Rotigotine—Dyspepsia—Valproic Acid—epilepsy syndrome	4.71e-05	0.00032	CcSEcCtD
Rotigotine—Skin disorder—Pregabalin—epilepsy syndrome	4.7e-05	0.000319	CcSEcCtD
Rotigotine—Hypertension—Gabapentin—epilepsy syndrome	4.69e-05	0.000318	CcSEcCtD
Rotigotine—Hyperhidrosis—Pregabalin—epilepsy syndrome	4.67e-05	0.000317	CcSEcCtD
Rotigotine—Vomiting—Clonazepam—epilepsy syndrome	4.67e-05	0.000317	CcSEcCtD
Rotigotine—Decreased appetite—Valproic Acid—epilepsy syndrome	4.65e-05	0.000316	CcSEcCtD
Rotigotine—Vomiting—Phenytoin—epilepsy syndrome	4.64e-05	0.000315	CcSEcCtD
Rotigotine—Rash—Clonazepam—epilepsy syndrome	4.63e-05	0.000314	CcSEcCtD
Rotigotine—Dermatitis—Clonazepam—epilepsy syndrome	4.63e-05	0.000314	CcSEcCtD
Rotigotine—Arthralgia—Gabapentin—epilepsy syndrome	4.62e-05	0.000314	CcSEcCtD
Rotigotine—Nausea—Felbamate—epilepsy syndrome	4.62e-05	0.000314	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	4.62e-05	0.000313	CcSEcCtD
Rotigotine—Vomiting—Oxcarbazepine—epilepsy syndrome	4.61e-05	0.000313	CcSEcCtD
Rotigotine—Fatigue—Valproic Acid—epilepsy syndrome	4.61e-05	0.000313	CcSEcCtD
Rotigotine—Anorexia—Pregabalin—epilepsy syndrome	4.61e-05	0.000313	CcSEcCtD
Rotigotine—Dizziness—Carbamazepine—epilepsy syndrome	4.6e-05	0.000313	CcSEcCtD
Rotigotine—Diarrhoea—Lamotrigine—epilepsy syndrome	4.6e-05	0.000313	CcSEcCtD
Rotigotine—Headache—Clonazepam—epilepsy syndrome	4.6e-05	0.000312	CcSEcCtD
Rotigotine—Rash—Phenytoin—epilepsy syndrome	4.6e-05	0.000312	CcSEcCtD
Rotigotine—Mental disorder—Topiramate—epilepsy syndrome	4.6e-05	0.000312	CcSEcCtD
Rotigotine—Dermatitis—Phenytoin—epilepsy syndrome	4.59e-05	0.000312	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	4.59e-05	0.000312	CcSEcCtD
Rotigotine—Rash—Oxcarbazepine—epilepsy syndrome	4.57e-05	0.000311	CcSEcCtD
Rotigotine—Pain—Valproic Acid—epilepsy syndrome	4.57e-05	0.000311	CcSEcCtD
Rotigotine—Constipation—Valproic Acid—epilepsy syndrome	4.57e-05	0.000311	CcSEcCtD
Rotigotine—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.57e-05	0.00031	CcSEcCtD
Rotigotine—Headache—Phenytoin—epilepsy syndrome	4.57e-05	0.00031	CcSEcCtD
Rotigotine—Erythema—Topiramate—epilepsy syndrome	4.57e-05	0.00031	CcSEcCtD
Rotigotine—Malnutrition—Topiramate—epilepsy syndrome	4.57e-05	0.00031	CcSEcCtD
Rotigotine—Discomfort—Gabapentin—epilepsy syndrome	4.57e-05	0.00031	CcSEcCtD
Rotigotine—Headache—Oxcarbazepine—epilepsy syndrome	4.55e-05	0.000309	CcSEcCtD
Rotigotine—Nausea—Zonisamide—epilepsy syndrome	4.53e-05	0.000307	CcSEcCtD
Rotigotine—Dry mouth—Gabapentin—epilepsy syndrome	4.52e-05	0.000307	CcSEcCtD
Rotigotine—Hypotension—Pregabalin—epilepsy syndrome	4.52e-05	0.000307	CcSEcCtD
Rotigotine—Confusional state—Gabapentin—epilepsy syndrome	4.47e-05	0.000304	CcSEcCtD
Rotigotine—Dizziness—Lamotrigine—epilepsy syndrome	4.45e-05	0.000302	CcSEcCtD
Rotigotine—Vomiting—Carbamazepine—epilepsy syndrome	4.43e-05	0.000301	CcSEcCtD
Rotigotine—Feeling abnormal—Valproic Acid—epilepsy syndrome	4.41e-05	0.000299	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	4.4e-05	0.000299	CcSEcCtD
Rotigotine—Infection—Gabapentin—epilepsy syndrome	4.4e-05	0.000299	CcSEcCtD
Rotigotine—Muscle spasms—Topiramate—epilepsy syndrome	4.39e-05	0.000298	CcSEcCtD
Rotigotine—Rash—Carbamazepine—epilepsy syndrome	4.39e-05	0.000298	CcSEcCtD
Rotigotine—Dermatitis—Carbamazepine—epilepsy syndrome	4.39e-05	0.000298	CcSEcCtD
Rotigotine—Insomnia—Pregabalin—epilepsy syndrome	4.37e-05	0.000297	CcSEcCtD
Rotigotine—Nausea—Clonazepam—epilepsy syndrome	4.36e-05	0.000296	CcSEcCtD
Rotigotine—Headache—Carbamazepine—epilepsy syndrome	4.36e-05	0.000296	CcSEcCtD
Rotigotine—Shock—Gabapentin—epilepsy syndrome	4.36e-05	0.000296	CcSEcCtD
Rotigotine—Nervous system disorder—Gabapentin—epilepsy syndrome	4.35e-05	0.000295	CcSEcCtD
Rotigotine—Paraesthesia—Pregabalin—epilepsy syndrome	4.34e-05	0.000295	CcSEcCtD
Rotigotine—Nausea—Phenytoin—epilepsy syndrome	4.33e-05	0.000294	CcSEcCtD
Rotigotine—Nausea—Oxcarbazepine—epilepsy syndrome	4.31e-05	0.000293	CcSEcCtD
Rotigotine—Skin disorder—Gabapentin—epilepsy syndrome	4.31e-05	0.000292	CcSEcCtD
Rotigotine—Somnolence—Pregabalin—epilepsy syndrome	4.3e-05	0.000292	CcSEcCtD
Rotigotine—Hyperhidrosis—Gabapentin—epilepsy syndrome	4.29e-05	0.000291	CcSEcCtD
Rotigotine—Tremor—Topiramate—epilepsy syndrome	4.28e-05	0.000291	CcSEcCtD
Rotigotine—Vomiting—Lamotrigine—epilepsy syndrome	4.28e-05	0.000291	CcSEcCtD
Rotigotine—Urticaria—Valproic Acid—epilepsy syndrome	4.25e-05	0.000288	CcSEcCtD
Rotigotine—Rash—Lamotrigine—epilepsy syndrome	4.24e-05	0.000288	CcSEcCtD
Rotigotine—Ill-defined disorder—Topiramate—epilepsy syndrome	4.24e-05	0.000288	CcSEcCtD
Rotigotine—Dermatitis—Lamotrigine—epilepsy syndrome	4.24e-05	0.000288	CcSEcCtD
Rotigotine—Anorexia—Gabapentin—epilepsy syndrome	4.23e-05	0.000287	CcSEcCtD
Rotigotine—Headache—Lamotrigine—epilepsy syndrome	4.22e-05	0.000286	CcSEcCtD
Rotigotine—Decreased appetite—Pregabalin—epilepsy syndrome	4.2e-05	0.000285	CcSEcCtD
Rotigotine—Agitation—Topiramate—epilepsy syndrome	4.2e-05	0.000285	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	4.17e-05	0.000283	CcSEcCtD
Rotigotine—Fatigue—Pregabalin—epilepsy syndrome	4.17e-05	0.000283	CcSEcCtD
Rotigotine—Hypotension—Gabapentin—epilepsy syndrome	4.14e-05	0.000281	CcSEcCtD
Rotigotine—Nausea—Carbamazepine—epilepsy syndrome	4.14e-05	0.000281	CcSEcCtD
Rotigotine—Constipation—Pregabalin—epilepsy syndrome	4.13e-05	0.000281	CcSEcCtD
Rotigotine—Pain—Pregabalin—epilepsy syndrome	4.13e-05	0.000281	CcSEcCtD
Rotigotine—Malaise—Topiramate—epilepsy syndrome	4.12e-05	0.00028	CcSEcCtD
Rotigotine—Vertigo—Topiramate—epilepsy syndrome	4.11e-05	0.000279	CcSEcCtD
Rotigotine—Syncope—Topiramate—epilepsy syndrome	4.1e-05	0.000278	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	4.04e-05	0.000274	CcSEcCtD
Rotigotine—Loss of consciousness—Topiramate—epilepsy syndrome	4.02e-05	0.000273	CcSEcCtD
Rotigotine—Insomnia—Gabapentin—epilepsy syndrome	4.01e-05	0.000272	CcSEcCtD
Rotigotine—Nausea—Lamotrigine—epilepsy syndrome	4e-05	0.000271	CcSEcCtD
Rotigotine—Cough—Topiramate—epilepsy syndrome	3.99e-05	0.000271	CcSEcCtD
Rotigotine—Feeling abnormal—Pregabalin—epilepsy syndrome	3.98e-05	0.000271	CcSEcCtD
Rotigotine—Paraesthesia—Gabapentin—epilepsy syndrome	3.98e-05	0.00027	CcSEcCtD
Rotigotine—Hypertension—Topiramate—epilepsy syndrome	3.95e-05	0.000268	CcSEcCtD
Rotigotine—Somnolence—Gabapentin—epilepsy syndrome	3.94e-05	0.000268	CcSEcCtD
Rotigotine—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.94e-05	0.000268	CcSEcCtD
Rotigotine—Dyspepsia—Gabapentin—epilepsy syndrome	3.9e-05	0.000265	CcSEcCtD
Rotigotine—Arthralgia—Topiramate—epilepsy syndrome	3.89e-05	0.000264	CcSEcCtD
Rotigotine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	3.86e-05	0.000262	CcSEcCtD
Rotigotine—Decreased appetite—Gabapentin—epilepsy syndrome	3.85e-05	0.000262	CcSEcCtD
Rotigotine—Discomfort—Topiramate—epilepsy syndrome	3.84e-05	0.000261	CcSEcCtD
Rotigotine—Urticaria—Pregabalin—epilepsy syndrome	3.84e-05	0.000261	CcSEcCtD
Rotigotine—Asthenia—Valproic Acid—epilepsy syndrome	3.84e-05	0.000261	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	3.83e-05	0.00026	CcSEcCtD
Rotigotine—Fatigue—Gabapentin—epilepsy syndrome	3.82e-05	0.00026	CcSEcCtD
Rotigotine—Dry mouth—Topiramate—epilepsy syndrome	3.8e-05	0.000258	CcSEcCtD
Rotigotine—Pain—Gabapentin—epilepsy syndrome	3.79e-05	0.000257	CcSEcCtD
Rotigotine—Constipation—Gabapentin—epilepsy syndrome	3.79e-05	0.000257	CcSEcCtD
Rotigotine—Pruritus—Valproic Acid—epilepsy syndrome	3.78e-05	0.000257	CcSEcCtD
Rotigotine—Confusional state—Topiramate—epilepsy syndrome	3.76e-05	0.000255	CcSEcCtD
Rotigotine—Infection—Topiramate—epilepsy syndrome	3.71e-05	0.000252	CcSEcCtD
Rotigotine—Shock—Topiramate—epilepsy syndrome	3.67e-05	0.000249	CcSEcCtD
Rotigotine—Diarrhoea—Valproic Acid—epilepsy syndrome	3.66e-05	0.000248	CcSEcCtD
Rotigotine—Nervous system disorder—Topiramate—epilepsy syndrome	3.66e-05	0.000248	CcSEcCtD
Rotigotine—Feeling abnormal—Gabapentin—epilepsy syndrome	3.65e-05	0.000248	CcSEcCtD
Rotigotine—Skin disorder—Topiramate—epilepsy syndrome	3.62e-05	0.000246	CcSEcCtD
Rotigotine—Hyperhidrosis—Topiramate—epilepsy syndrome	3.61e-05	0.000245	CcSEcCtD
Rotigotine—Hypersensitivity—Pregabalin—epilepsy syndrome	3.56e-05	0.000242	CcSEcCtD
Rotigotine—Anorexia—Topiramate—epilepsy syndrome	3.55e-05	0.000241	CcSEcCtD
Rotigotine—Dizziness—Valproic Acid—epilepsy syndrome	3.54e-05	0.00024	CcSEcCtD
Rotigotine—Urticaria—Gabapentin—epilepsy syndrome	3.52e-05	0.000239	CcSEcCtD
Rotigotine—Hypotension—Topiramate—epilepsy syndrome	3.48e-05	0.000237	CcSEcCtD
Rotigotine—Asthenia—Pregabalin—epilepsy syndrome	3.47e-05	0.000236	CcSEcCtD
Rotigotine—Pruritus—Pregabalin—epilepsy syndrome	3.42e-05	0.000232	CcSEcCtD
Rotigotine—Vomiting—Valproic Acid—epilepsy syndrome	3.4e-05	0.000231	CcSEcCtD
Rotigotine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.4e-05	0.000231	CcSEcCtD
Rotigotine—Insomnia—Topiramate—epilepsy syndrome	3.37e-05	0.000229	CcSEcCtD
Rotigotine—Rash—Valproic Acid—epilepsy syndrome	3.37e-05	0.000229	CcSEcCtD
Rotigotine—Dermatitis—Valproic Acid—epilepsy syndrome	3.37e-05	0.000229	CcSEcCtD
Rotigotine—Headache—Valproic Acid—epilepsy syndrome	3.35e-05	0.000227	CcSEcCtD
Rotigotine—Paraesthesia—Topiramate—epilepsy syndrome	3.35e-05	0.000227	CcSEcCtD
Rotigotine—Somnolence—Topiramate—epilepsy syndrome	3.32e-05	0.000225	CcSEcCtD
Rotigotine—Diarrhoea—Pregabalin—epilepsy syndrome	3.31e-05	0.000225	CcSEcCtD
Rotigotine—Dyspepsia—Topiramate—epilepsy syndrome	3.28e-05	0.000223	CcSEcCtD
Rotigotine—Hypersensitivity—Gabapentin—epilepsy syndrome	3.27e-05	0.000222	CcSEcCtD
Rotigotine—Decreased appetite—Topiramate—epilepsy syndrome	3.24e-05	0.00022	CcSEcCtD
Rotigotine—Gastrointestinal disorder—Topiramate—epilepsy syndrome	3.22e-05	0.000219	CcSEcCtD
Rotigotine—Fatigue—Topiramate—epilepsy syndrome	3.22e-05	0.000218	CcSEcCtD
Rotigotine—Dizziness—Pregabalin—epilepsy syndrome	3.2e-05	0.000217	CcSEcCtD
Rotigotine—Pain—Topiramate—epilepsy syndrome	3.19e-05	0.000217	CcSEcCtD
Rotigotine—Constipation—Topiramate—epilepsy syndrome	3.19e-05	0.000217	CcSEcCtD
Rotigotine—Asthenia—Gabapentin—epilepsy syndrome	3.18e-05	0.000216	CcSEcCtD
Rotigotine—Nausea—Valproic Acid—epilepsy syndrome	3.18e-05	0.000216	CcSEcCtD
Rotigotine—Pruritus—Gabapentin—epilepsy syndrome	3.14e-05	0.000213	CcSEcCtD
Rotigotine—Vomiting—Pregabalin—epilepsy syndrome	3.07e-05	0.000209	CcSEcCtD
Rotigotine—Feeling abnormal—Topiramate—epilepsy syndrome	3.07e-05	0.000209	CcSEcCtD
Rotigotine—Rash—Pregabalin—epilepsy syndrome	3.05e-05	0.000207	CcSEcCtD
Rotigotine—Dermatitis—Pregabalin—epilepsy syndrome	3.05e-05	0.000207	CcSEcCtD
Rotigotine—Diarrhoea—Gabapentin—epilepsy syndrome	3.03e-05	0.000206	CcSEcCtD
Rotigotine—Headache—Pregabalin—epilepsy syndrome	3.03e-05	0.000206	CcSEcCtD
Rotigotine—Urticaria—Topiramate—epilepsy syndrome	2.96e-05	0.000201	CcSEcCtD
Rotigotine—Dizziness—Gabapentin—epilepsy syndrome	2.93e-05	0.000199	CcSEcCtD
Rotigotine—Nausea—Pregabalin—epilepsy syndrome	2.87e-05	0.000195	CcSEcCtD
Rotigotine—Vomiting—Gabapentin—epilepsy syndrome	2.82e-05	0.000191	CcSEcCtD
Rotigotine—Rash—Gabapentin—epilepsy syndrome	2.8e-05	0.00019	CcSEcCtD
Rotigotine—Dermatitis—Gabapentin—epilepsy syndrome	2.79e-05	0.00019	CcSEcCtD
Rotigotine—Headache—Gabapentin—epilepsy syndrome	2.78e-05	0.000189	CcSEcCtD
Rotigotine—Hypersensitivity—Topiramate—epilepsy syndrome	2.75e-05	0.000187	CcSEcCtD
Rotigotine—Asthenia—Topiramate—epilepsy syndrome	2.68e-05	0.000182	CcSEcCtD
Rotigotine—Pruritus—Topiramate—epilepsy syndrome	2.64e-05	0.000179	CcSEcCtD
Rotigotine—Nausea—Gabapentin—epilepsy syndrome	2.63e-05	0.000179	CcSEcCtD
Rotigotine—Diarrhoea—Topiramate—epilepsy syndrome	2.55e-05	0.000173	CcSEcCtD
Rotigotine—Dizziness—Topiramate—epilepsy syndrome	2.47e-05	0.000167	CcSEcCtD
Rotigotine—Vomiting—Topiramate—epilepsy syndrome	2.37e-05	0.000161	CcSEcCtD
Rotigotine—Rash—Topiramate—epilepsy syndrome	2.35e-05	0.00016	CcSEcCtD
Rotigotine—Dermatitis—Topiramate—epilepsy syndrome	2.35e-05	0.00016	CcSEcCtD
Rotigotine—Headache—Topiramate—epilepsy syndrome	2.34e-05	0.000159	CcSEcCtD
Rotigotine—Nausea—Topiramate—epilepsy syndrome	2.22e-05	0.00015	CcSEcCtD
Rotigotine—CYP3A4—Metabolism—ALAD—epilepsy syndrome	3.52e-06	4.31e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—H2AFX—epilepsy syndrome	3.51e-06	4.3e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MEF2C—epilepsy syndrome	3.51e-06	4.29e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.5e-06	4.29e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—S100B—epilepsy syndrome	3.49e-06	4.28e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—HTR7—epilepsy syndrome	3.48e-06	4.27e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—AVP—epilepsy syndrome	3.46e-06	4.24e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—SOCS3—epilepsy syndrome	3.46e-06	4.24e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CDC42—epilepsy syndrome	3.45e-06	4.23e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—FGF2—epilepsy syndrome	3.44e-06	4.21e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—YWHAZ—epilepsy syndrome	3.43e-06	4.21e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—TSC2—epilepsy syndrome	3.41e-06	4.18e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—AGT—epilepsy syndrome	3.41e-06	4.17e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—NGF—epilepsy syndrome	3.4e-06	4.16e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—YWHAZ—epilepsy syndrome	3.39e-06	4.15e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—HBEGF—epilepsy syndrome	3.38e-06	4.14e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	3.36e-06	4.12e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	3.36e-06	4.12e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—NGF—epilepsy syndrome	3.35e-06	4.1e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—AVP—epilepsy syndrome	3.34e-06	4.09e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—APOE—epilepsy syndrome	3.34e-06	4.09e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—AKT3—epilepsy syndrome	3.32e-06	4.07e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CCR5—epilepsy syndrome	3.3e-06	4.05e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	3.3e-06	4.04e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	3.3e-06	4.04e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—POMC—epilepsy syndrome	3.3e-06	4.04e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	3.29e-06	4.03e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—HES1—epilepsy syndrome	3.27e-06	4.01e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—KDR—epilepsy syndrome	3.27e-06	4.01e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CCR5—epilepsy syndrome	3.26e-06	3.99e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—ADAM10—epilepsy syndrome	3.24e-06	3.97e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—HTR2A—epilepsy syndrome	3.23e-06	3.96e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—CCL2—epilepsy syndrome	3.23e-06	3.95e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ADSL—epilepsy syndrome	3.22e-06	3.95e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—RELA—epilepsy syndrome	3.19e-06	3.91e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—HTR2A—epilepsy syndrome	3.19e-06	3.91e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—FYN—epilepsy syndrome	3.18e-06	3.9e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	3.18e-06	3.89e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—H2AFX—epilepsy syndrome	3.17e-06	3.88e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MEF2C—epilepsy syndrome	3.17e-06	3.88e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GLUL—epilepsy syndrome	3.16e-06	3.87e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—HES1—epilepsy syndrome	3.16e-06	3.87e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—PRKCB—epilepsy syndrome	3.15e-06	3.86e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—IL6ST—epilepsy syndrome	3.14e-06	3.84e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—MTOR—epilepsy syndrome	3.13e-06	3.83e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	3.1e-06	3.8e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	3.09e-06	3.79e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	3.08e-06	3.77e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.07e-06	3.76e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—FYN—epilepsy syndrome	3.07e-06	3.76e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—TSC2—epilepsy syndrome	3.07e-06	3.76e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—AGT—epilepsy syndrome	3.07e-06	3.76e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—S100B—epilepsy syndrome	3.07e-06	3.76e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—H2AFX—epilepsy syndrome	3.06e-06	3.75e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—YWHAZ—epilepsy syndrome	3.06e-06	3.75e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MEF2C—epilepsy syndrome	3.06e-06	3.74e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—SOCS3—epilepsy syndrome	3.04e-06	3.72e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—TSC2—epilepsy syndrome	3.03e-06	3.71e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CDC42—epilepsy syndrome	3.03e-06	3.71e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—AGT—epilepsy syndrome	3.03e-06	3.71e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—NGF—epilepsy syndrome	3.02e-06	3.7e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	3.01e-06	3.69e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—APOE—epilepsy syndrome	3.01e-06	3.68e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—APOE—epilepsy syndrome	2.97e-06	3.63e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—YWHAZ—epilepsy syndrome	2.95e-06	3.62e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—KDR—epilepsy syndrome	2.94e-06	3.61e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CCR5—epilepsy syndrome	2.94e-06	3.6e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—AVP—epilepsy syndrome	2.93e-06	3.59e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—NGF—epilepsy syndrome	2.92e-06	3.58e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—KDR—epilepsy syndrome	2.9e-06	3.56e-05	CbGpPWpGaD
Rotigotine—DRD5—GPCR downstream signaling—AKT1—epilepsy syndrome	2.9e-06	3.56e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.9e-06	3.55e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—HTR2A—epilepsy syndrome	2.88e-06	3.53e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—CASP3—epilepsy syndrome	2.88e-06	3.52e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—POMC—epilepsy syndrome	2.87e-06	3.51e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CCR5—epilepsy syndrome	2.84e-06	3.48e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—PRKCB—epilepsy syndrome	2.83e-06	3.47e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—IL6ST—epilepsy syndrome	2.82e-06	3.46e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.82e-06	3.45e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CCL2—epilepsy syndrome	2.81e-06	3.44e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—PRKCB—epilepsy syndrome	2.8e-06	3.42e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—JUN—epilepsy syndrome	2.79e-06	3.42e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—IL6ST—epilepsy syndrome	2.79e-06	3.41e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—HTR2A—epilepsy syndrome	2.78e-06	3.4e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—HES1—epilepsy syndrome	2.77e-06	3.4e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—TSC2—epilepsy syndrome	2.74e-06	3.35e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—AGT—epilepsy syndrome	2.73e-06	3.35e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Hemostasis—AKT1—epilepsy syndrome	2.72e-06	3.33e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—MMP9—epilepsy syndrome	2.72e-06	3.33e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—FYN—epilepsy syndrome	2.7e-06	3.3e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	2.69e-06	3.29e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—H2AFX—epilepsy syndrome	2.69e-06	3.29e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MEF2C—epilepsy syndrome	2.68e-06	3.29e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—APOE—epilepsy syndrome	2.68e-06	3.28e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	2.64e-06	3.24e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—TSC2—epilepsy syndrome	2.64e-06	3.23e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—AGT—epilepsy syndrome	2.64e-06	3.23e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling by GPCR—AKT1—epilepsy syndrome	2.64e-06	3.23e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—BCHE—epilepsy syndrome	2.63e-06	3.22e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—KDR—epilepsy syndrome	2.62e-06	3.21e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	2.62e-06	3.21e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	2.61e-06	3.19e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—YWHAZ—epilepsy syndrome	2.59e-06	3.18e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.59e-06	3.17e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—APOE—epilepsy syndrome	2.58e-06	3.17e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—POMC—epilepsy syndrome	2.58e-06	3.16e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—NGF—epilepsy syndrome	2.56e-06	3.14e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—POMC—epilepsy syndrome	2.55e-06	3.12e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	2.55e-06	3.12e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	2.55e-06	3.12e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—FGF2—epilepsy syndrome	2.54e-06	3.11e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—KDR—epilepsy syndrome	2.53e-06	3.1e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CCL2—epilepsy syndrome	2.53e-06	3.09e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—PRKCB—epilepsy syndrome	2.52e-06	3.09e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—IL6ST—epilepsy syndrome	2.51e-06	3.08e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	2.51e-06	3.07e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—SRC—epilepsy syndrome	2.51e-06	3.07e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CCR5—epilepsy syndrome	2.49e-06	3.05e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CCL2—epilepsy syndrome	2.49e-06	3.05e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	2.48e-06	3.04e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—TH—epilepsy syndrome	2.47e-06	3.03e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—VEGFA—epilepsy syndrome	2.44e-06	2.99e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—HTR2A—epilepsy syndrome	2.44e-06	2.99e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—PRKCB—epilepsy syndrome	2.44e-06	2.98e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—IL6ST—epilepsy syndrome	2.43e-06	2.97e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.36e-06	2.89e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—RELA—epilepsy syndrome	2.35e-06	2.88e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	2.35e-06	2.88e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—TSC2—epilepsy syndrome	2.32e-06	2.84e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—AGT—epilepsy syndrome	2.32e-06	2.84e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MTOR—epilepsy syndrome	2.31e-06	2.83e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—POMC—epilepsy syndrome	2.3e-06	2.82e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—FGF2—epilepsy syndrome	2.28e-06	2.8e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—APOE—epilepsy syndrome	2.27e-06	2.78e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—FGF2—epilepsy syndrome	2.25e-06	2.76e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CCL2—epilepsy syndrome	2.25e-06	2.76e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	2.24e-06	2.74e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—BCHE—epilepsy syndrome	2.23e-06	2.73e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—KDR—epilepsy syndrome	2.22e-06	2.72e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—POMC—epilepsy syndrome	2.22e-06	2.72e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CCL2—epilepsy syndrome	2.17e-06	2.66e-05	CbGpPWpGaD
Rotigotine—DRD4—GPCR downstream signaling—AKT1—epilepsy syndrome	2.14e-06	2.62e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—PRKCB—epilepsy syndrome	2.14e-06	2.62e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—IL6ST—epilepsy syndrome	2.13e-06	2.61e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	2.13e-06	2.6e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—CASP3—epilepsy syndrome	2.12e-06	2.6e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—RELA—epilepsy syndrome	2.12e-06	2.6e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	2.1e-06	2.58e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—TH—epilepsy syndrome	2.1e-06	2.57e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—RELA—epilepsy syndrome	2.09e-06	2.56e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MTOR—epilepsy syndrome	2.08e-06	2.55e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.08e-06	2.54e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	2.06e-06	2.53e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.06e-06	2.53e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—JUN—epilepsy syndrome	2.06e-06	2.53e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MTOR—epilepsy syndrome	2.05e-06	2.51e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—CAT—epilepsy syndrome	2.04e-06	2.5e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—FGF2—epilepsy syndrome	2.03e-06	2.49e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.02e-06	2.48e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.01e-06	2.46e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—MMP9—epilepsy syndrome	2.01e-06	2.46e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.98e-06	2.43e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	1.96e-06	2.4e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—POMC—epilepsy syndrome	1.95e-06	2.39e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling by GPCR—AKT1—epilepsy syndrome	1.95e-06	2.38e-05	CbGpPWpGaD
Rotigotine—DRD1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.93e-06	2.36e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—CASP3—epilepsy syndrome	1.91e-06	2.34e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	1.91e-06	2.34e-05	CbGpPWpGaD
Rotigotine—DRD3—GPCR downstream signaling—AKT1—epilepsy syndrome	1.9e-06	2.33e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—RELA—epilepsy syndrome	1.89e-06	2.31e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—CASP3—epilepsy syndrome	1.89e-06	2.31e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—JUN—epilepsy syndrome	1.86e-06	2.27e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MTOR—epilepsy syndrome	1.85e-06	2.27e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—SRC—epilepsy syndrome	1.85e-06	2.27e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.84e-06	2.26e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—JUN—epilepsy syndrome	1.83e-06	2.24e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	1.82e-06	2.23e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.81e-06	2.22e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—MMP9—epilepsy syndrome	1.81e-06	2.21e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—VEGFA—epilepsy syndrome	1.8e-06	2.21e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	1.79e-06	2.19e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—MMP9—epilepsy syndrome	1.78e-06	2.18e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling by GPCR—AKT1—epilepsy syndrome	1.75e-06	2.15e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	1.75e-06	2.14e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling by GPCR—AKT1—epilepsy syndrome	1.73e-06	2.12e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.73e-06	2.12e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—CAT—epilepsy syndrome	1.73e-06	2.11e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	1.72e-06	2.11e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.72e-06	2.11e-05	CbGpPWpGaD
Rotigotine—ADRA2B—GPCR downstream signaling—AKT1—epilepsy syndrome	1.72e-06	2.1e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—CASP3—epilepsy syndrome	1.7e-06	2.09e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	1.68e-06	2.06e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—SRC—epilepsy syndrome	1.67e-06	2.04e-05	CbGpPWpGaD
Rotigotine—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.66e-06	2.03e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—JUN—epilepsy syndrome	1.65e-06	2.03e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	1.64e-06	2.01e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—SRC—epilepsy syndrome	1.64e-06	2.01e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.64e-06	2.01e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.62e-06	1.99e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—VEGFA—epilepsy syndrome	1.62e-06	1.99e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—TH—epilepsy syndrome	1.62e-06	1.98e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.62e-06	1.98e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—MMP9—epilepsy syndrome	1.61e-06	1.97e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—VEGFA—epilepsy syndrome	1.6e-06	1.96e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—RELA—epilepsy syndrome	1.6e-06	1.96e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	1.6e-06	1.96e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.58e-06	1.94e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	1.57e-06	1.92e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—GPX1—epilepsy syndrome	1.56e-06	1.91e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling by GPCR—AKT1—epilepsy syndrome	1.56e-06	1.91e-05	CbGpPWpGaD
Rotigotine—DRD5—Signaling Pathways—AKT1—epilepsy syndrome	1.56e-06	1.91e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	1.55e-06	1.9e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	1.51e-06	1.85e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—SRC—epilepsy syndrome	1.48e-06	1.82e-05	CbGpPWpGaD
Rotigotine—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.46e-06	1.78e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—VEGFA—epilepsy syndrome	1.44e-06	1.77e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	1.44e-06	1.77e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	1.43e-06	1.75e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—JUN—epilepsy syndrome	1.4e-06	1.72e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	1.39e-06	1.71e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—AGT—epilepsy syndrome	1.37e-06	1.68e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	1.36e-06	1.67e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.36e-06	1.67e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.35e-06	1.65e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—APOE—epilepsy syndrome	1.34e-06	1.64e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.33e-06	1.63e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	1.32e-06	1.62e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.3e-06	1.59e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—SRC—epilepsy syndrome	1.26e-06	1.54e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.24e-06	1.52e-05	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	1.22e-06	1.5e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.2e-06	1.48e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—POMC—epilepsy syndrome	1.15e-06	1.41e-05	CbGpPWpGaD
Rotigotine—DRD4—Signaling Pathways—AKT1—epilepsy syndrome	1.15e-06	1.41e-05	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.08e-06	1.33e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.06e-06	1.29e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—ALB—epilepsy syndrome	1.05e-06	1.29e-05	CbGpPWpGaD
Rotigotine—DRD1—Signaling Pathways—AKT1—epilepsy syndrome	1.03e-06	1.27e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.03e-06	1.27e-05	CbGpPWpGaD
Rotigotine—DRD3—Signaling Pathways—AKT1—epilepsy syndrome	1.02e-06	1.25e-05	CbGpPWpGaD
Rotigotine—ADRA2B—Signaling Pathways—AKT1—epilepsy syndrome	9.22e-07	1.13e-05	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	9.19e-07	1.13e-05	CbGpPWpGaD
Rotigotine—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	8.9e-07	1.09e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—POMC—epilepsy syndrome	8.89e-07	1.09e-05	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—ALB—epilepsy syndrome	8.11e-07	9.93e-06	CbGpPWpGaD
Rotigotine—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	7.81e-07	9.57e-06	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	7.09e-07	8.68e-06	CbGpPWpGaD
Rotigotine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	5.45e-07	6.68e-06	CbGpPWpGaD
Rotigotine—CYP1A2—Metabolism—AKT1—epilepsy syndrome	4.62e-07	5.66e-06	CbGpPWpGaD
Rotigotine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	3.56e-07	4.36e-06	CbGpPWpGaD
